CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Laura Francis

Chief Executive Officer and Director, SI-BONE, Inc.

Search every verified Laura Francis interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Laura Francis, CEO and director of SI-BONE, discussed the company’s focus on clinical data and reimbursement strategies in a June 2026 podcast with spine surgeon Dr. Pierce Nunley. She stated that SI joint fusion coverage by Medicare and commercial payers was achieved through over 10 years of work, including randomized controlled trial data, and noted the company recently launched a single-use posterior device kit, with potential for in-office use by 2027. Francis also said that only about 10% of patients needing SI joint fusion are currently treated. In September 2025, Francis participated in an opening keynote at LSI Europe ’25 with Antoine Papiernik of Sofinnova Partners, where she described SI-BONE as a publicly traded orthopedics company generating around $200 million in revenue and becoming profitable. She commented that medical device industry valuations are at historical lows despite company growth, and discussed the potential impact of artificial intelligence on preoperative planning in orthopedics. In earlier appearances, Francis reflected on her transition from CFO to CEO, the importance of financial discipline given closed capital markets, and the challenges of balancing a demanding CEO role with family life.

Recent appearances

  • Inside SI-BONE: Laura Francis, CEO, on Clinical Data & the Future of SI Joint Fusion

    June 08, 2026 · 📺 Global Spine Initiative

    In this episode, spine surgeon Dr. Pierce Nunley interviews Laura Francis, CEO of SI-Bone‪@thesacroiliacjoint‬, about the company’s journey, the importance of clinical data, and the future of SI joint fusion. They discuss research funding, payer strategy, and the evolving landscape of minimally invasive spine procedures. Key Takeaways • Importance of clinical data in medical device approval • Strategies for payer reimbursement and coverage • Development of SI joint fusion products and techniques Watch the full episode to learn how evidence-based innovation and cross-specialty collaboration…

    Watch on YouTube ↗

  • Opening Keynote with Antoine Papiernik and Laura Francis | LSI Europe '25

    September 25, 2025 · 📺 LSI - Life Science Intelligence™

    This Keynote took place at LSI Europe ‘25 Emerging Medtech Summit in London. The Opening Keynote at LSI Europe ’25 sets the stage for a week of innovation and collaboration in medtech. Antoine Papiernik of Sofinnova Partners and Laura Francis of SI-BONE outline the trends, challenges, and opportunities shaping the future of healthcare technology. This Keynote featured: Scott Pantel — LSI Antoine Papiernik — Sofinnova Partners Laura Francis — SI-BONE Our Next Events: LSI USA '26 (Dana Point) March 16th - 20th, 2026 At the Waldorf Astoria Monarch Beach Resort Register today: https://www.lsius…

    Watch on YouTube ↗

  • Why SI-BONE May Be the Most Underrated Success Story in Medtech

    June 24, 2025 · 📺 State of MedTech.

    Laura Francis, CEO of SI-BONE, joins The State of Medtech to share how she helped transform the company from a niche innovator into a category-defining, publicly traded leader in sacropelvic surgery. In this deep-dive conversation, we cover: → Why randomized controlled trials set SI-BONE apart → How Laura transitioned from CFO to CEO and led the company through IPO → Why profitability matters more than ever in medtech → The strategic shift into pain management and how it reshaped their market → What it really takes to defend against fast followers → Advice for future medtech leaders—especiall…

    Watch on YouTube ↗

  • Podcast Ep. 21 Laura Francis Stanford MBA ’95 meets Aislin Roth MBA ’25

    April 28, 2025 · 📺 Katharine McLennan

    Today, I’m joined by Laura Francis from the Stanford MBA Class of 1995 and Aislin Roth from the Class of 2025. Laura is the CEO of SI-BONE (Nasdaq: SIBN), a global leader in the medical device industry. She recently joined the board of Bruker Corporation (Nasdaq: BRKR), a life science and diagnostics company, and was previously a board member for Shockwave Medical (Nasdaq: SWAV) prior to its acquisition by Johnson & Johnson. She also serves as an executive board member of the Medical Device Manufacturers Association, advocating for the future of the medtech industry and mentoring the next ge…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →